Efficacy of stimulation therapy for parienets with Retinitis pigmentasa

Efficacy of Transcleral stimulation therapy (TES) for parienets with Retinitis pigmentasa

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201401299820N6

Enrollment

Registered

2017-02-20

Start date

2017-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transcleral Stimulation. Hereditary retinal dystrophy

Interventions

Transcleral Stimulation based on specific protocol for each person in 20 min.

Rehabilitation

Transcleral Stimulation based on specific protocol for each person in 20 min

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: inclusion critria:Age between 18-50 ;RP detection with VA better than 0.05 Exlusion critria:Comorbidity like cataract,diabet,Ocular surface or any ocular surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Visual Acuity. Timepoint: 12 week. Method of measurement: Snellen Chart.	—

Secondary

Measure	Time frame
Visual Function. Timepoint: 12 week. Method of measurement: Questionair.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Elham Ashrafi

Farabi Eye Research Center,Tehran University of Medical Sciences

El.Ashrafi@gmail.com+98 21 5542 1001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026